Abraham Ceesay - Chief Executive Officer, Director at Rapport Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
RAPP on Nasdaq
All Insider Reports
All Insider Reports

Abraham Ceesay - trading volume in the past year for Rapport Therapeutics, Inc.

Holdings reported by Abraham Ceesay for Rapport Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 556,247 $16,575,214 $29.80 18 Feb 2026 Direct
Common Stock 81,729 $2,161,732 $26.45 18 Feb 2026 By Ceesay Family Irrevocable Trust
Common Stock 20,729 $617,651 $29.80 18 Feb 2026 By Dorothy Ceesay Irrevocable Trust
Stock Option (Right to Buy) 428,000 02 Feb 2026 Direct Common Stock

Transactions reported by Abraham Ceesay for Rapport Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.